MY102313A - Bornane derivatives - Google Patents
Bornane derivativesInfo
- Publication number
- MY102313A MY102313A MYPI88000060A MYPI19880060A MY102313A MY 102313 A MY102313 A MY 102313A MY PI88000060 A MYPI88000060 A MY PI88000060A MY PI19880060 A MYPI19880060 A MY PI19880060A MY 102313 A MY102313 A MY 102313A
- Authority
- MY
- Malaysia
- Prior art keywords
- bornane
- derivatives
- arabinose
- xylose
- ribose
- Prior art date
Links
- 150000001636 bornane derivatives Chemical class 0.000 title abstract 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 abstract 4
- PYMYPHUHKUWMLA-VPENINKCSA-N aldehydo-D-xylose Chemical compound OC[C@@H](O)[C@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-VPENINKCSA-N 0.000 abstract 2
- HMFHBZSHGGEWLO-AIHAYLRMSA-N alpha-D-ribose Chemical group OC[C@H]1O[C@H](O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-AIHAYLRMSA-N 0.000 abstract 2
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical group OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 abstract 2
- UUNIOFWUJYBVGQ-UHFFFAOYSA-N 2-amino-4-(3,4-dimethoxyphenyl)-10-fluoro-4,5,6,7-tetrahydrobenzo[1,2]cyclohepta[6,7-d]pyran-3-carbonitrile Chemical compound C1=C(OC)C(OC)=CC=C1C1C(C#N)=C(N)OC2=C1CCCC1=CC=C(F)C=C12 UUNIOFWUJYBVGQ-UHFFFAOYSA-N 0.000 abstract 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 abstract 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 abstract 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 230000000840 anti-viral effect Effects 0.000 abstract 1
- 239000003443 antiviral agent Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000009833 condensation Methods 0.000 abstract 1
- 230000005494 condensation Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
-
- E—FIXED CONSTRUCTIONS
- E04—BUILDING
- E04H—BUILDINGS OR LIKE STRUCTURES FOR PARTICULAR PURPOSES; SWIMMING OR SPLASH BATHS OR POOLS; MASTS; FENCING; TENTS OR CANOPIES, IN GENERAL
- E04H1/00—Buildings or groups of buildings for dwelling or office purposes; General layout, e.g. modular co-ordination or staggered storeys
- E04H1/12—Small buildings or other erections for limited occupation, erected in the open air or arranged in buildings, e.g. kiosks, waiting shelters for bus stops or for filling stations, roofs for railway platforms, watchmen's huts or dressing cubicles
- E04H1/1272—Exhibition stands
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
- F16B—DEVICES FOR FASTENING OR SECURING CONSTRUCTIONAL ELEMENTS OR MACHINE PARTS TOGETHER, e.g. NAILS, BOLTS, CIRCLIPS, CLAMPS, CLIPS OR WEDGES; JOINTS OR JOINTING
- F16B2/00—Friction-grip releasable fastenings
- F16B2/20—Clips, i.e. with gripping action effected solely by the inherent resistance to deformation of the material of the fastening
Landscapes
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Architecture (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Civil Engineering (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Structural Engineering (AREA)
- Medicinal Chemistry (AREA)
- Mechanical Engineering (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Virology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB848410484A GB8410484D0 (en) | 1984-04-24 | 1984-04-24 | Antiviral and antibacterial compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY102313A true MY102313A (en) | 1992-05-28 |
Family
ID=10560013
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI88000060A MY102313A (en) | 1984-04-24 | 1988-01-26 | Bornane derivatives |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US4720487A (enExample) |
| JP (2) | JPS60233096A (enExample) |
| AR (2) | AR241916A1 (enExample) |
| AT (2) | AT388557B (enExample) |
| BE (2) | BE902232A (enExample) |
| CA (2) | CA1265129A (enExample) |
| CH (2) | CH664572A5 (enExample) |
| DE (2) | DE3514637A1 (enExample) |
| DK (2) | DK160832C (enExample) |
| DZ (1) | DZ772A1 (enExample) |
| ES (2) | ES8606380A1 (enExample) |
| FI (2) | FI78302C (enExample) |
| FR (3) | FR2563106B1 (enExample) |
| GB (3) | GB8410484D0 (enExample) |
| HK (2) | HK18788A (enExample) |
| IE (2) | IE58323B1 (enExample) |
| IT (2) | IT1215265B (enExample) |
| LU (2) | LU85865A1 (enExample) |
| MA (2) | MA20414A1 (enExample) |
| MY (1) | MY102313A (enExample) |
| NL (2) | NL193067C (enExample) |
| NO (2) | NO161121C (enExample) |
| OA (2) | OA08000A (enExample) |
| PT (2) | PT80324B (enExample) |
| SE (2) | SE462973B (enExample) |
| ZA (2) | ZA852367B (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7622492B2 (en) | 2005-08-31 | 2009-11-24 | Hoffmann-La Roche Inc. | Pyrazolones as inhibitors of 11β-hydroxysteroid dehydrogenase |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3868361A (en) * | 1973-03-12 | 1975-02-25 | Richard L Tolman | s-Triazolo{8 2,3-A{9 {0 pryimidine nucleosides |
| DE3019322A1 (de) * | 1980-05-21 | 1981-12-03 | Merck Patent Gmbh, 6100 Darmstadt | Psychopharmakon sowie verwendung von adenosinderivaten |
-
1984
- 1984-04-24 GB GB848410484A patent/GB8410484D0/en active Pending
-
1985
- 1985-03-28 ZA ZA852367A patent/ZA852367B/xx unknown
- 1985-03-28 ZA ZA852366A patent/ZA852366B/xx unknown
- 1985-04-01 US US06/718,065 patent/US4720487A/en not_active Expired - Fee Related
- 1985-04-01 US US06/718,064 patent/US4704454A/en not_active Expired - Fee Related
- 1985-04-10 AR AR85300028A patent/AR241916A1/es active
- 1985-04-10 AR AR85300029A patent/AR241917A1/es active
- 1985-04-17 SE SE8501885A patent/SE462973B/sv not_active IP Right Cessation
- 1985-04-17 SE SE8501884A patent/SE462972B/sv not_active IP Right Cessation
- 1985-04-18 BE BE0/214872A patent/BE902232A/fr not_active IP Right Cessation
- 1985-04-18 CH CH1666/85A patent/CH664572A5/fr not_active IP Right Cessation
- 1985-04-18 CH CH1665/85A patent/CH665837A5/fr not_active IP Right Cessation
- 1985-04-18 BE BE0/214871A patent/BE902231A/fr not_active IP Right Cessation
- 1985-04-19 MA MA20638A patent/MA20414A1/fr unknown
- 1985-04-19 MA MA20639A patent/MA20415A1/fr unknown
- 1985-04-22 LU LU85865A patent/LU85865A1/fr unknown
- 1985-04-22 LU LU85864A patent/LU85864A1/fr unknown
- 1985-04-22 FI FI851577A patent/FI78302C/fi not_active IP Right Cessation
- 1985-04-22 IT IT8520439A patent/IT1215265B/it active
- 1985-04-22 IT IT20440/85A patent/IT1201415B/it active
- 1985-04-22 PT PT80324A patent/PT80324B/pt not_active IP Right Cessation
- 1985-04-22 FI FI851576A patent/FI78301C/fi not_active IP Right Cessation
- 1985-04-22 PT PT80325A patent/PT80325B/pt not_active IP Right Cessation
- 1985-04-23 IE IE103085A patent/IE58323B1/en not_active IP Right Cessation
- 1985-04-23 NL NL8501171A patent/NL193067C/nl not_active IP Right Cessation
- 1985-04-23 DE DE19853514637 patent/DE3514637A1/de active Granted
- 1985-04-23 NO NO851619A patent/NO161121C/no unknown
- 1985-04-23 ES ES542486A patent/ES8606380A1/es not_active Expired
- 1985-04-23 DE DE19853514641 patent/DE3514641A1/de active Granted
- 1985-04-23 CA CA000479845A patent/CA1265129A/en not_active Expired - Lifetime
- 1985-04-23 DK DK181285A patent/DK160832C/da not_active IP Right Cessation
- 1985-04-23 GB GB08510328A patent/GB2157690B/en not_active Expired
- 1985-04-23 NO NO851620A patent/NO161122C/no unknown
- 1985-04-23 GB GB08510329A patent/GB2158436B/en not_active Expired
- 1985-04-23 CA CA000479844A patent/CA1241649A/en not_active Expired
- 1985-04-23 DZ DZ850084A patent/DZ772A1/fr active
- 1985-04-23 ES ES542485A patent/ES8606379A1/es not_active Expired
- 1985-04-23 NL NL8501170A patent/NL193109B/xx not_active Application Discontinuation
- 1985-04-23 DK DK181385A patent/DK160833C/da not_active IP Right Cessation
- 1985-04-23 IE IE102985A patent/IE58322B1/en not_active IP Right Cessation
- 1985-04-24 AT AT0122585A patent/AT388557B/de not_active IP Right Cessation
- 1985-04-24 AT AT0122685A patent/AT388558B/de not_active IP Right Cessation
- 1985-04-24 OA OA58577A patent/OA08000A/xx unknown
- 1985-04-24 JP JP60086617A patent/JPS60233096A/ja active Granted
- 1985-04-24 JP JP60086616A patent/JPS60233095A/ja active Granted
- 1985-04-24 FR FR8506204A patent/FR2563106B1/fr not_active Expired
- 1985-04-24 FR FR8506206A patent/FR2563107B1/fr not_active Expired
- 1985-04-24 FR FR8506207A patent/FR2563224B1/fr not_active Expired
- 1985-04-24 OA OA58576A patent/OA07999A/xx unknown
-
1988
- 1988-01-26 MY MYPI88000060A patent/MY102313A/en unknown
- 1988-03-10 HK HK187/88A patent/HK18788A/xx not_active IP Right Cessation
-
1989
- 1989-02-02 HK HK102/89A patent/HK10289A/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CZ142195A3 (en) | Injectable composition containing derivatives of taxan group | |
| NO178189C (no) | Tetrazolmellomprodukter | |
| PT79840A (en) | Process for the preparation of polipeptides with alpha-amilase inhibiting action and pharmaceutical compositions therewith | |
| JPS55162799A (en) | 6beta* 7beta* 15*166dimethylenee1*44 androstadienee33one* its manufacture and antiandrosterone medicine blend containing it and having antihypertensive and diuretic activity | |
| IT1209415B (it) | Composizioni di sterilizzanti di vinilalogenuri, di bassa tossicita'. | |
| DE3578744D1 (de) | Natriumarmes, als kochsalzsubstitut geeignetes salzgemisch. | |
| ES8403910A1 (es) | Procedimiento para la preparacion de nitratos de amino-deso-xi-1.4;3.6-dianhidro-hexito,asi como de sus sales de adicionacida farmacologicamente inocuas | |
| IL77124A (en) | 5-alkyl-1-phenyl-2-piperazinoalkylpyrazolin-3-one compoundds,their preparation and pharmaceutical compositions containing them | |
| SE8103580L (sv) | N?726-substituerade adenosiner | |
| MY102313A (en) | Bornane derivatives | |
| ES472640A1 (es) | Procedimiento para preparar seudotrisacaridos | |
| ZA872664B (en) | Six-membered heterocyclic derivatives of n'-substituted-n,n'-diacylhydrazines | |
| ES470274A1 (es) | Procedimiento de preparacion de nuevos derivados de benzo- (b)-tienopiridinas | |
| IL66028A0 (en) | Saturated aminocyclitol derivatives,their preparation and pharmaceutical compositions containing them | |
| ES1016349Y (es) | Mamparo tubular. | |
| OA07701A (fr) | Perfectionnements relatifs à des dérivés de benzothiénylglycyl-céphalosporines. | |
| DK385485D0 (da) | Midler, indeholdende phosphorheterocyclisk forbindelser, til bekaempelse af skadelige organismer | |
| GB1469234A (en) | Compositions containing dithionites -hydrosulphites- | |
| ES8601958A1 (es) | Procedimiento para la obtencion de4-metil-4-fenil-1,3-dioxolanos, de efecto perfumante | |
| SE8205837L (sv) | Isopropylaminopyrimidinderivat, dess framstellning och terapeutiska kompositioner innehallande dessa | |
| DE69020576D1 (de) | 1,4-bis(alkylamino)-2,3-diaza-anthracen-9,10-dione. | |
| JPS53108987A (en) | Preparation of 1-(2'-tetrahydrofuryl)-5-fluorouracil | |
| KR840009308A (ko) | 환으로 치환된 피라지노 이소퀴놀린 유도체의 제조방법 | |
| BR8106865A (pt) | Composicao solida de peroxido organico | |
| OA07702A (fr) | Perfectionnements relatifs à des dérivés de naphtylglycyl-céphalosporines. |